Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1986 1
1987 1
1990 2
1994 1
2002 1
2003 1
2004 2
2007 2
2008 2
2009 4
2010 6
2011 1
2012 7
2013 5
2014 11
2015 17
2016 16
2017 15
2018 15
2019 17
2020 20
2021 10
2022 14
2023 23
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Results by year

Filters applied: . Clear all
Page 1
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).
Abou-Alfa GK, Lau G, Kudo M, Chan SL, Kelley RK, Furuse J, Sukeepaisarnjaroen W, Kang YK, Dao TV, De Toni EN, Rimassa L, Breder V, Vasilyev A, Heurgué A, Tam VC, Mody K, Thungappa SC, Ostapenko Y, Yau T, Azevedo S, Varela M, Cheng AL, Qin S, Galle PR, Ali S, Gupta C, Makowsky M, Kurland JF, Negro A, Sangro B. Abou-Alfa GK, et al. Among authors: vasilyev a. Future Oncol. 2023 Dec;19(38):2505-2516. doi: 10.2217/fon-2023-0486. Epub 2023 Sep 6. Future Oncol. 2023. PMID: 37671641 Free article. Review.
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study.
Psyrri A, Fayette J, Harrington K, Gillison M, Ahn MJ, Takahashi S, Weiss J, Machiels JP, Baxi S, Vasilyev A, Karpenko A, Dvorkin M, Hsieh CY, Thungappa SC, Segura PP, Vynnychenko I, Haddad R, Kasper S, Mauz PS, Baker V, He P, Evans B, Wildsmith S, Olsson RF, Yovine A, Kurland JF, Morsli N, Seiwert TY; KESTREL Investigators. Psyrri A, et al. Among authors: vasilyev a. Ann Oncol. 2023 Mar;34(3):262-274. doi: 10.1016/j.annonc.2022.12.008. Epub 2022 Dec 16. Ann Oncol. 2023. PMID: 36535565 Free article. Clinical Trial.
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.
Abou-Alfa GK, Lau G, Kudo M, Chan SL, Kelley RK, Furuse J, Sukeepaisarnjaroen W, Kang YK, Van Dao T, De Toni EN, Rimassa L, Breder V, Vasilyev A, Heurgué A, Tam VC, Mody K, Thungappa SC, Ostapenko Y, Yau T, Azevedo S, Varela M, Cheng AL, Qin S, Galle PR, Ali S, Marcovitz M, Makowsky M, He P, Kurland JF, Negro A, Sangro B. Abou-Alfa GK, et al. Among authors: vasilyev a. NEJM Evid. 2022 Aug;1(8):EVIDoa2100070. doi: 10.1056/EVIDoa2100070. Epub 2022 Jun 6. NEJM Evid. 2022. PMID: 38319892
[New directions of immunocorrection in multiple sclerosis].
Boyko AN, Khachanova NV, Melnikov MV, Sivertseva SA, Evdoshenko EP, Spirin NN, Vasilyev AV, Rozenson OL. Boyko AN, et al. Among authors: vasilyev av. Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(2):103-109. doi: 10.17116/jnevro2020120021103. Zh Nevrol Psikhiatr Im S S Korsakova. 2020. PMID: 32307419 Review. Russian.
Decoding Heterogenous Single-cell Perturbation Responses.
Song B, Liu D, Dai W, McMyn N, Wang Q, Yang D, Krejci A, Vasilyev A, Untermoser N, Loregger A, Song D, Williams B, Rosen B, Cheng X, Chao L, Kale HT, Zhang H, Diao Y, Bürckstümmer T, Siliciano JM, Li JJ, Siliciano R, Huangfu D, Li W. Song B, et al. Among authors: vasilyev a. bioRxiv [Preprint]. 2023 Nov 29:2023.10.30.564796. doi: 10.1101/2023.10.30.564796. bioRxiv. 2023. PMID: 37961332 Free PMC article. Preprint.
[Biofilm control in urological practice].
Aitsev AV, Vasilyev AO, Shiryaev AA, Kim YA, Arefieva OA, Govorov AV, Pushkar DY. Aitsev AV, et al. Among authors: vasilyev ao. Urologiia. 2022 Mar;(1):81-88. Urologiia. 2022. PMID: 35274866 Review. Russian.
Alkenylation of Arenes and Heteroarenes with Alkynes.
Boyarskiy VP, Ryabukhin DS, Bokach NA, Vasilyev AV. Boyarskiy VP, et al. Among authors: vasilyev av. Chem Rev. 2016 May 25;116(10):5894-986. doi: 10.1021/acs.chemrev.5b00514. Epub 2016 Apr 25. Chem Rev. 2016. PMID: 27111159 Review.
3D Printed Gene-Activated Sodium Alginate Hydrogel Scaffolds.
Khvorostina MA, Mironov AV, Nedorubova IA, Bukharova TB, Vasilyev AV, Goldshtein DV, Komlev VS, Popov VK. Khvorostina MA, et al. Among authors: vasilyev av. Gels. 2022 Jul 6;8(7):421. doi: 10.3390/gels8070421. Gels. 2022. PMID: 35877506 Free PMC article.
189 results